A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults

Condition:   Rabies Interventions:   Biological: Rabipur®;   Biological: Rabies mRNA vaccine CV7202 Dose level 1;   Biological: Rabies mRNA vaccine CV7202 Dose level 2;   Biological: Rabies mRNA vaccine CV7202 Dose level 3;   Biological: Rabies mRNA vaccine CV7202 Dose level 4;   Biological: Rabies mRNA vaccine CV7202 Dose l evel 5;   Biological: Rabies mRNA vaccine CV7202 Dose level 6 Sponsor:   CureVac AG Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Rabies | Study | Vaccines